Skip to content

Effects of Nitrates and Citrulline Malate on Performance in Professional Professional Soccer

Experimental Study to Evaluate the Effects of Effects of a Sports Supplement Based on Nitrates and Citrulline Malate on Performance in Professional Soccer Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05525871
Acronym
NiCiFut
Enrollment
40
Registered
2022-09-02
Start date
2022-08-15
Completion date
2023-01-20
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supplementation

Keywords

Nitrates, Citrulline malate, Soccer

Brief summary

Randomized, single-center, parallel, team-stratified, stratified experimental study to evaluate the efficacy of a high sports supplement in improving high-intensity intermittent exercise performance in professional female soccer players.

Detailed description

Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned). The product to be consumed will be Nitrates and Citrulline Malate. Participants will consume the product for 30 days. The intake should be done two hours before each training session and the same dose will be consumed. The women's soccer players will perform a stress test with gas analysis to measure performance, as well as a Wingate test without consumption of the products. Five days later, the players will perform the Yo-Yo IR1 test in the field and will repeat the same tests performed at the beginning of the test after product consumption.

Interventions

DIETARY_SUPPLEMENTControl product

Fruit puree

DIETARY_SUPPLEMENTNitrates and Citrulline Malate

Female soccer players should consume the experimental product for 30 days to evaluate the efficacy of a sports supplement high in nitrates combined with citrulline malate in the improvement of performance in high-intensity intermittent exercise. high intensity

Sponsors

Universidad Católica San Antonio de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Present at the time of signing the informed consent at the age between 18 and 40 years. * Female. * Healthy subjects without any chronic disease. * Volunteers capable of understanding the clinical study, willing to give their written informed. consent and comply with the procedures and requirements of the study. and requirements of the study.

Exclusion criteria

* Players who change teams during the experimental study. * Smoking subjects. * Subjects using mouthwashes during the study. * Subjects with a history of drug, alcohol or other substance abuse or other factors that limit their ability to cooperate during the study. factors that limit their ability to cooperate during the study. * Subjects whose status makes them ineligible for the study, at the discretion of the investigator discretion of the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Fatigue in jumpingChange in initial jump fatigue at 30 daysMeasured with a contact platform
Aerobic and anaerobic thresholds - VO2maxChange in initial maximal oxygen consumption at 30 daysMeasured with a gas analyzer
Anaerobic capacityChange in baseline anaerobic capacity at 30 daysMeasured with a Monark cycloergometer

Secondary

MeasureTime frameDescription
Microcapillary bloodIt will be measured on two different occasions. Day one and 30 days later.This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood.
LactateIt will be measured on two different occasions. One on the first day (without intake of product ) and 30 days later, the same measurements but after having consumed the productLactate levels will be measured using the Lactate Pro
Safety variablesIt will be measured on two different occasions. Day one and 30 days later.It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026